Swedish Orphan Biovitrum AB (publ)
BIOVF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,357 | $94,864 | $98,952 | $105,025 |
| - Cash | $110 | $1,058 | $997 | $1,140 |
| + Debt | $1,439 | $12,813 | $14,021 | $16,735 |
| Enterprise Value | $11,686 | $106,619 | $111,976 | $120,620 |
| Revenue | $823 | $6,175 | $6,465 | $7,436 |
| % Growth | -86.7% | -4.5% | -13.1% | – |
| Gross Profit | -$134 | $4,749 | $4,876 | $5,836 |
| % Margin | -16.3% | 76.9% | 75.4% | 78.5% |
| EBITDA | $387 | $1,899 | $2,296 | $2,593 |
| % Margin | 47% | 30.8% | 35.5% | 34.9% |
| Net Income | -$307 | $636 | $875 | $1,397 |
| % Margin | -37.2% | 10.3% | 13.5% | 18.8% |
| EPS Diluted | -0.89 | 1.83 | 2.52 | 4.03 |
| % Growth | -148.6% | -27.4% | -37.5% | – |
| Operating Cash Flow | $195 | $1,448 | $2,295 | $1,797 |
| Capital Expenditures | -$1 | -$421 | -$11 | -$61 |
| Free Cash Flow | $194 | $1,027 | $2,284 | $1,736 |